Literature DB >> 35384286

.   

Abstract

Entities:  

Year:  2022        PMID: 35384286      PMCID: PMC8980972          DOI: 10.1111/jcmm.17270

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


× No keyword cloud information.
In Ting Zhu et al, the images of A549‐Vector (Migration, left panel) group and A549‐shRNA1 (Migration) group in Figure 2B contain errors. The correct figure is shown below. The authors confirm all results and conclusions of this article remain unchanged.
FIGURE 2

DUXAP9‐206 promotes NSCLC cell proliferation and invasion in vitro. (A) Representative micrographs of wound closures at 0 and 24 h after wounding. (B) The indicated invading or migrating cells analysed by Matrigel‐coated or noncoated Transwell assays, respectively. (C) Quantification of the indicated invading or migrating cells in 5 random fields analysed by Transwell assays. *p < 0.05. (D) MTT assays were performed in the indicated cells. (E) Representative micrographs (left panel) and quantification (right panel) of colony formation. *p < 0.05

DUXAP9‐206 promotes NSCLC cell proliferation and invasion in vitro. (A) Representative micrographs of wound closures at 0 and 24 h after wounding. (B) The indicated invading or migrating cells analysed by Matrigel‐coated or noncoated Transwell assays, respectively. (C) Quantification of the indicated invading or migrating cells in 5 random fields analysed by Transwell assays. *p < 0.05. (D) MTT assays were performed in the indicated cells. (E) Representative micrographs (left panel) and quantification (right panel) of colony formation. *p < 0.05
  1 in total

1.  LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.

Authors:  Ting Zhu; Shu An; Man-Ting Choy; Junhao Zhou; Shanshan Wu; Shihua Liu; Bangdong Liu; Zhicheng Yao; Xun Zhu; Jueheng Wu; Zhenjian He
Journal:  J Cell Mol Med       Date:  2018-12-04       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.